Pantel K - Search Results

1

BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood.

Bednarz N, Eltze E, Semjonow A, Rink M, Andreas A, Mulder L, Hannemann J, Fisch M, Pantel K, Weier HU, Bielawski KP, Brandt B. Bednarz N, et al. Among authors: pantel k. Clin Cancer Res. 2010 Jul 1;16(13):3340-8. doi: 10.1158/1078-0432.CCR-10-0150. Epub 2010 Jun 30. Clin Cancer Res. 2010. PMID: 20592016 Free PMC article.

2

Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.

Passlick B, Izbicki JR, Kubuschok B, Nathrath W, Thetter O, Pichlmeier U, Schweiberer L, Riethmüller G, Pantel K. Passlick B, et al. Among authors: pantel k. J Clin Oncol. 1994 Sep;12(9):1827-32. doi: 10.1200/JCO.1994.12.9.1827. J Clin Oncol. 1994. PMID: 8083707

3

Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer.

Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, Passlick B, Broelsch CE, Pantel K. Izbicki JR, et al. Among authors: pantel k. N Engl J Med. 1997 Oct 23;337(17):1188-94. doi: 10.1056/NEJM199710233371702. N Engl J Med. 1997. PMID: 9337377 Free article.

4

Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer.

Schaller G, Fuchs I, Pritze W, Ebert A, Herbst H, Pantel K, Weitzel H, Lengyel E. Schaller G, et al. Among authors: pantel k. Clin Cancer Res. 1996 Nov;2(11):1879-85. Clin Cancer Res. 1996. PMID: 9816144

5

Comparative immunocytochemical assessment of isolated carcinoma cells in lymph nodes and bone marrow of patients with clinically localized prostate cancer.

Köllermann J, Heseding B, Helpap B, Köllermann MW, Pantel K. Köllermann J, et al. Among authors: pantel k. Int J Cancer. 1999 Apr 20;84(2):145-9. doi: 10.1002/(sici)1097-0215(19990420)84:2<145::aid-ijc9>3.0.co;2-5. Int J Cancer. 1999. PMID: 10096246

6

Detection and clinical importance of micrometastatic disease.

Pantel K, Cote RJ, Fodstad O. Pantel K, et al. J Natl Cancer Inst. 1999 Jul 7;91(13):1113-24. doi: 10.1093/jnci/91.13.1113. J Natl Cancer Inst. 1999. PMID: 10393719 Review.

7

Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer.

Kubuschok B, Passlick B, Izbicki JR, Thetter O, Pantel K. Kubuschok B, et al. Among authors: pantel k. J Clin Oncol. 1999 Jan;17(1):19-24. doi: 10.1200/JCO.1999.17.1.19. J Clin Oncol. 1999. PMID: 10458213

8

Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer.

Hosch S, Kraus J, Scheunemann P, Izbicki JR, Schneider C, Schumacher U, Witter K, Speicher MR, Pantel K. Hosch S, et al. Among authors: pantel k. Cancer Res. 2000 Dec 15;60(24):6836-40. Cancer Res. 2000. PMID: 11156375

9

MAGE-A gene expression pattern in primary breast cancer.

Otte M, Zafrakas M, Riethdorf L, Pichlmeier U, Löning T, Jänicke F, Pantel K. Otte M, et al. Among authors: pantel k. Cancer Res. 2001 Sep 15;61(18):6682-7. Cancer Res. 2001. PMID: 11559535

10

Molecular determinants of occult metastatic tumor cells in bone marrow.

Pantel K, Braun S. Pantel K, et al. Clin Breast Cancer. 2001 Oct;2(3):222-8. doi: 10.3816/CBC.2001.n.025. Clin Breast Cancer. 2001. PMID: 11899416 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

682 results

Search Page

Filters